3 articles
The FDA has significantly reduced drug approval times, cutting average reviews by up to two months. This efficiency drive, aided by AI, aims to bring life-saving treatments to patients faster without compromising safety. Pharmaceutical companies are set to benefit from quicker market access and potentially lower R&D costs.
Gaia Fertility is using AI to make IVF treatments more predictable and affordable, offering a "no baby, no fee" guarantee. This innovative approach aims to reduce the significant financial and emotional stress often associated with fertility treatments. By leveraging data and AI, the company promises a clearer, more cost-effective path to parenthood for struggling couples.
Advancements in cystic fibrosis treatment have more than doubled life expectancy, forcing a significant reevaluation of financial planning, retirement goals, and long-term career viability for affected individuals. The shift from survival to sustained living introduces new uncertainties and market opportunities.
